Clinical Trial Update: European Study of Cerebral Aspergillosis Treated With Isavuconazole

View source ↗

Summary

This completed European trial evaluates isavuconazole for cerebral aspergillosis, within the broader context of invasive aspergillosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Aspergillosis
• Invasive Aspergillosis

Drugs mentioned

• Cresemba (isavuconazole)

Snippet

Sponsor: Imagine Institute | Conditions: Cerebral Aspergillosis, Invasive Aspergillosis | Status: COMPLETED